Issue 35, 2023

Harnessing the dual antimicrobial mode of action with a lipophilic Mn(ii) complex using the principle of the Irving–Williams Series to completely eradicate Staphylococcus aurous

Abstract

The judicious selection of 5,7-dibromo-2-methy-8-quinolinol (BQ) as a Mn(II) ionophore results in the synthesis of Mn(BQ)2(DMSO)2·DMSO (1), a potent metalloantibiotic with a dual antimicrobial mode of action against four different strains of Staphylococcus aurous (SA) bacteria (MIC = 0.625 μg mL−1). Additionally, 1 can overcome ciprofloxacin-resistance in methicillin-resistant SA bacteria.

Graphical abstract: Harnessing the dual antimicrobial mode of action with a lipophilic Mn(ii) complex using the principle of the Irving–Williams Series to completely eradicate Staphylococcus aurous

Supplementary files

Article information

Article type
Communication
Submitted
19 Jun 2023
Accepted
15 Aug 2023
First published
16 Aug 2023

Dalton Trans., 2023,52, 12203-12207

Harnessing the dual antimicrobial mode of action with a lipophilic Mn(II) complex using the principle of the Irving–Williams Series to completely eradicate Staphylococcus aurous

K. Mudarmah, B. Bagale, G. Chen, J. A. Krause, J. D. Mighion and S. D. Huang, Dalton Trans., 2023, 52, 12203 DOI: 10.1039/D3DT01904G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements